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Adverse Drug Effects 
  Common terms often used interchangeably 
  Adverse drug effect 
  Adverse drug event/Adverse event 
  Adverse drug reaction 
  “Side effect” 
  Adverse drug effect (ADE) is synonymous with 
       adverse drug reaction (ADR) 
  Adverse drug event is synonymous with adverse event (AE) 
  Adverse event (AE) is defined as any untoward medical occurrence in a 
patient administered a medicinal product which does not necessarily have 
a causal relationship with this treatment 
  Adverse drug reaction (ADR) is defined as all noxious and unintended 
responses to a medicinal product related to any dose 
  ADRs are thus a subset of  AEs 
  Distinction between side effect and ADR 










Inspired by: http://www.slideshare.net/DrVijayBhushanam/vj-ad-rs 
Motivation to Study ADRs 
  Significant burden on population, as 68% of  US population is 
taking at least one prescription drug (Mayo Clinic, 2013) 
  40% of  adults aged 65+ take 5 to 9 concurrent medications 
  Studies have shown that ADRs result in increases in morbidity, 
mortality, as well as increases healthcare costs 
  Most recent data shows over 2 million people in the US are 
impacted by ADRs by death, hospitalization or serious injury  
  100K fatalities 
  1.5 million hospital visits 
  ADRs can occur in US patients during hospitalizations  
 
Motivation to Study ADRs 
(cont.) 
  Meta-analysis in 2002 found that 4.9% of  hospitalizations 
were associated with ADRs 
  28.9% of  these were considered preventable 
  More recent study in 2012 found 2% of  inpatients and 1.6% 
of  outpatients had preventable ADRs 
  This study also suggests that approximately half  of  ADRs are 
preventable among both outpatients and inpatients 
  28% of  ER visits due to drugs, 70% of  these were preventable 
FDA Adverse Event Reporting 
System (FAERS) 
  Database that contains information on adverse event (AEs) and 
medication reports submitted to the US Food and Drug 
Administration (FDA) 
  Voluntary for healthcare professionals (physicians, pharmacists, 
nurses) to report AEs 
  Often healthcare professionals will report AEs to product 
manufacturer 
  Mandatory for product manufacturers to submit report to FDA for 
entry into FAERS 
  Limitations of  data 
  No certainty that reported event actually due to product 
  FDA does not require causal relationship 
  FDA does not receive reports for every AE that occurs with a product 
  Available to the public as an open data set! 
FAERS (cont.) 
  FDA uses FAERS to discover new safety concerns related to 
a marketed product 
  Also uses FAERS to monitor manufacturer’s compliance 
with reporting regulations 
  Data structure conforms to international safety reporting 
guidance issued by ICH  
  AEs coded to terms in Medication Dictionary for Regulatory 
Activities (MedDRA) terminology 
MedDRA 
  Hierarchy of  5 levels 
  Specific or most granular terms 
(LLTs) through broad groupings by 
etiology, manifestation site, or 
purpose (SOCs) 
  Preferred Term (PT) is a distinct 
descriptor or single medical concept 
for a symptom, sign, disease 
diagnosis, therapeutic indication, 
investigation, surgical or medical 
procedure 
  FAERS data uses PTs http://www.meddra.org/how-to-use/basics/hierarchy 
FAERS Data Characteristics 
OpenFDA initiative provides FAERS data via RESTful API 
  Limitations on requests per minute/per day 
  API Key available to increase limits 
  Useful for a limited project using infrequent requests 
  Difficult to leverage all available data for a broad analysis 
  Data also provided via a series of  downloads (used in this 
project) 
  Data packaged in zip files by quarter 
  Packages available in both XML format and ASCII text 
character-delimited format files 
  Data ranges from Q1 2004 through Q1 2015 
FAERS Data Characteristics  
(cont.) 
  Each quarter of  FAERS data is a separate download link (not ideal) 
  Used Firefox Web Developer to select innerHTML surrounding download URL 
  Copied HTML into vim and trimmed down to raw URL 
  Used bash script with curl to automated download process 
  Once script completed there were 45 zip files, total size of  736MB compressed 
  Each zip file contains a few documentation files and the raw ASCII character-
delimited data in .txt files 
  Used bash script to extract files to a single directory for simplicity 
  Lots of  duplicate documentation (Readme.doc/pdf) files, so used unzip option 
to prevent overwriting files with same filename 
  Converted .doc/.pdf  documentation to plaintext using Apache Tika, removed 
duplicate documentation using SHA1 sums to compare files 
   Total uncompressed size of  all ASCII text files is 3.8GB 
FAERS Data Characteristics 
(cont.) 
  Total of  385 ASCII text files representing 9 discrete categories 
Category Description 
DEMO Patient demographics for each event 
DRUG Drug info report for each event 
INDI MedDRA terms coded for the indications for use 
(diagnoses) for the reported drugs 
OUTC Patient outcomes for each event 
REAC MedDRA terms coded for the event 
RPSR Report sources for the event 
SIZE File sizes and record counts for all data (discontinued 
after Q3’12) 
STAT Gives null counts and frequency (discontinued after 
Q3’12) 
THER Drug therapy start dates and end dates for the reported 
drugs 
Architecture 
  Want to leverage open source 
distributed computational tools for 
processing extracted FAERS data 
  No easy access to multiple 
commodity machines for building 
cluster 
  Instead utilize server class hardware 
used for research and analysis 
  Dell Precision T7610 workstation 
  128GB RAM, 12-core Xeon 
E5-2697 2.7GHz 
  Ubuntu Linux 14.04 
  Employ Hadoop, Apache Spark, and 
PySpark for convenient data loading, 
cleaning, and analysis 
  Use Docker to run multiple isolated 













Ubuntu Linux/Native OS 
Hadoop Overview 
  Open source Java-based distributed 
storage and processing platform, derived 
from Google’s publication of  a similar 
proprietary platform for large data sets 
  Leverages commodity hardware 
  “Big Data” tool used by Yahoo, 
FaceBook, Twitter (large organizations 
with Petabytes of  data) and others with 
smaller data sets 
  Provides ecosystem of  tools that 
accompany primary computational 
engine (MapReduce) 
Hadoop distributed filesystem (HDFS) 
  Hive, Pig, HBase 
  This project utilizes HDFS for 
distributed storage 
  ASCII data files loaded into HDFS 
https://twitter.com/daviottenheimer/status/532661754820829185 
Apache Spark Overview 
  Open source, Java-based alternative to 
Hadoop MapReduce platform 
  Execution engine optimized for in-
memory computing, compared to 
Hadoop’s disk-based engine 
  Leverages existing data concepts: 
SQL-based query language and 
DataFrames (inspired from R 
language and Python’s Pandas) 
  Up to 100X faster than Hadoop in 
memory, 3X on disk 
  Supports interactive data exploration 
from Python, R, Scala 
  Largely compatible with Hadoop 
ecosystem tools and data 
  Primary abstraction is Resilient 
Distributed Dataset (RDD), 
collection of  elements partitioned 
across the nodes of  a cluster 
Docker Overview 
  Challenge:  Hadoop tools and Apache Spark require significant time to 
install and configure 
  Utilize numerous TCP ports for subcomponents to enable communication 
between worker and master processes 
  Difficult to run multiple worker processes if  default ports are the same 
  Orchestration of  components across multiple machines in a cluster is tedious 
Docker allows application isolation, provides OS-level virtualization 
  Similar to a VM but lightweight (uses Linux kernel namespaces and 
cgroups), uses existing OS resources instead of  emulation host hardware 
  Uses the concept of  containers to package a pre-configured application 
  Containers are versatile and can move between systems 
Docker repository of  pre-built containers for a host of  applications 
  Use existing repo images for Hadoop, Apache Spark, and iPython with 
PySpark for interactive analysis 
  Each application runs in an isolation container, using a virtual IP address 
  Containers communicate with each other (as well as the host) using standard 
networking protocols 
Data Exploration- Challenges 
  Filenames are mostly consistent (e.g. DEMO04Q1.TXT) but some are 
lowercase or the extension is lowercase (.txt) 
  Data formats change at least once for each category (DEMO, DRUG, 
INDI, etc.) 
  FAERS added additional columns in these change 
  File header with column labels is thus variable and must be accommodated 
  In some categories the schema of  the data is altered 3 or 4 times between Q1 
2004 to Q1 2015 
  E.g. DRUG and REAC both undergo 3 schema alterations, DEMO 4 
  All categories changed formats in 2012Q4 
  We use the common fields and schema that exist for the whole range of  data 
  Since AEs are often user reported, many entries are incomplete or have 
missing data 
  STAT and SIZE files are not regularly-formatted tabular files, but 
rather generated reports, thus are excluded from analysis 
Data Exploration - Schemas 
'DEMO' : "id event_dt mrf_dt fda_dt mfr_name age age_unit sex weight 
weight_unit” 
'DRUG' : "id drug_seq role_code drugname dose dechal rechal exp_dt” 
'INDI' : "id drug_seq indi_pt” 
'OUTC' : "id outcome_code” 
'REAC' : "id pt" 
'RPSR' : "id report_code" 
'THER' : "id drug_seq start_dt end_dt duration duration_unit" 
Data Exploration - Code 
Data Exploration - Code (cont.)  
Data Exploration - Code (cont.) 
Examples 
Count distinct drug name values and sort by 










































  ADRs and AEs worthy of  exploration and further research, 
to help decrease associated morbidity, mortality and costs 
  FAERS data set provides a convenient, open, and free 
resource for exploring trends in reported ADRs/AEs 
  Distributed open source computational platforms (i.e. 
Hadoop and Apache Spark) provide a free, convenient 
mechanism to analyze large data sets 
Docker and pre-built Docker images can help alleviate some 
of  the troublesome installation and configuration pains 
  Time to analysis is reduced by leveraging these tools 
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